ATE301662T1 - Pyrimidin-4-one derivate, verfahren zu ihrer herstellung and sie enthaltende zusammensetzungen - Google Patents

Pyrimidin-4-one derivate, verfahren zu ihrer herstellung and sie enthaltende zusammensetzungen

Info

Publication number
ATE301662T1
ATE301662T1 AT02290945T AT02290945T ATE301662T1 AT E301662 T1 ATE301662 T1 AT E301662T1 AT 02290945 T AT02290945 T AT 02290945T AT 02290945 T AT02290945 T AT 02290945T AT E301662 T1 ATE301662 T1 AT E301662T1
Authority
AT
Austria
Prior art keywords
pyrimidine
derivatives
production
compositions containing
compositions
Prior art date
Application number
AT02290945T
Other languages
German (de)
English (en)
Inventor
Gilbert Lavielle
Thierry Dubuffet
Olivier Muller
Mark Millan
Anne Dekeyne
Mauricette Brocco
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE301662T1 publication Critical patent/ATE301662T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02290945T 2001-04-18 2002-04-16 Pyrimidin-4-one derivate, verfahren zu ihrer herstellung and sie enthaltende zusammensetzungen ATE301662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105216A FR2823752B1 (fr) 2001-04-18 2001-04-18 Nouveaux derives de pyrimidin-4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE301662T1 true ATE301662T1 (de) 2005-08-15

Family

ID=8862407

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02290945T ATE301662T1 (de) 2001-04-18 2002-04-16 Pyrimidin-4-one derivate, verfahren zu ihrer herstellung and sie enthaltende zusammensetzungen

Country Status (22)

Country Link
US (1) US6747032B2 (enExample)
EP (1) EP1256583B1 (enExample)
JP (1) JP3781698B2 (enExample)
CN (1) CN1181075C (enExample)
AR (1) AR034308A1 (enExample)
AT (1) ATE301662T1 (enExample)
AU (1) AU781663B2 (enExample)
BR (1) BR0201312A (enExample)
CA (1) CA2383315C (enExample)
DE (1) DE60205424T2 (enExample)
DK (1) DK1256583T3 (enExample)
EA (1) EA005402B1 (enExample)
ES (1) ES2246380T3 (enExample)
FR (1) FR2823752B1 (enExample)
HU (1) HUP0201255A3 (enExample)
MX (1) MXPA02003849A (enExample)
NO (1) NO328014B1 (enExample)
NZ (1) NZ518425A (enExample)
PL (1) PL207047B1 (enExample)
PT (1) PT1256583E (enExample)
SI (1) SI1256583T1 (enExample)
ZA (1) ZA200203086B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2680789C (en) * 2006-03-28 2016-02-16 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP3581567A1 (en) 2011-04-10 2019-12-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2958924B1 (en) * 2013-02-22 2016-12-28 Bristol-Myers Squibb Company 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1)
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722194B1 (fr) * 1994-07-06 1996-08-23 Adir Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent
FR2764890B1 (fr) * 1997-06-24 1999-08-27 Adir Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MXPA02004735A (es) * 1999-11-12 2003-01-28 Orive Javier Uhthoff Compuestos heteroaromaticos, biciclicos y triciclicos.

Also Published As

Publication number Publication date
EP1256583B1 (fr) 2005-08-10
CA2383315C (fr) 2008-02-05
DE60205424T2 (de) 2006-07-13
DK1256583T3 (da) 2005-10-31
EA200200379A3 (ru) 2002-12-26
CN1381456A (zh) 2002-11-27
SI1256583T1 (sl) 2005-12-31
PT1256583E (pt) 2005-10-31
HU0201255D0 (enExample) 2002-06-29
ZA200203086B (en) 2002-10-28
PL353511A1 (en) 2002-10-21
EA005402B1 (ru) 2005-02-24
FR2823752A1 (fr) 2002-10-25
JP3781698B2 (ja) 2006-05-31
HUP0201255A2 (hu) 2002-12-28
AR034308A1 (es) 2004-02-18
EP1256583A1 (fr) 2002-11-13
CA2383315A1 (fr) 2002-10-18
HK1049669A1 (en) 2003-05-23
HUP0201255A3 (en) 2003-02-28
NZ518425A (en) 2003-08-29
NO328014B1 (no) 2009-11-09
NO20021806L (no) 2002-10-21
AU3440602A (en) 2002-10-24
PL207047B1 (pl) 2010-10-29
FR2823752B1 (fr) 2004-10-22
NO20021806D0 (no) 2002-04-17
ES2246380T3 (es) 2006-02-16
US6747032B2 (en) 2004-06-08
BR0201312A (pt) 2003-06-10
MXPA02003849A (es) 2003-07-14
EA200200379A2 (ru) 2002-10-31
AU781663B2 (en) 2005-06-02
DE60205424D1 (de) 2005-09-15
JP2002356486A (ja) 2002-12-13
US20030087916A1 (en) 2003-05-08
CN1181075C (zh) 2004-12-22

Similar Documents

Publication Publication Date Title
ATE263754T1 (de) Substituierte sulfonylaminomethylbenzoesäure(derivate) und verfahren zu ihrer herstellung
DE502004007000D1 (de) Stickstoff substituierte hexahydro-pyrazino 1,2-a pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE502004011328D1 (de) Substituierte hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE60233058D1 (de) Silsesquioxanderivate und verfahren zu ihrer herstellung
DE60033028D1 (de) 5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung
ATE344034T1 (de) N-adamantylmethyl-derivate und zwischenprodukte als pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
DE10393704D2 (de) Nancomposite, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE327981T1 (de) Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
DE50200914D1 (de) Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE301121T1 (de) Neue 7-azaindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung
DE50213372D1 (de) Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament
ATE337317T1 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen
DE60234678D1 (de) Leiterplatte und verfahren zu ihrer herstellung
DE60224880D1 (de) Mikrobolometer und verfahren zu dessen herstellung
DE50011818D1 (de) Hochkratzfeste mehrschichtlackierung, verfahren zu ihrer herstellung und ihre verwendung
ATE305471T1 (de) Naphthyridine derivate, verfahren zu ihrer herstellung, deren anwendung und sie enthaltende pharmazeutische zusammensetzungen
DE60237251D1 (de) Kationenaustauscher, Verfahren zu dessen Herstellung und dessen Verwendung
DE60205717D1 (de) 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE60204015D1 (de) Piperidincarboxamid-derivate, ein verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen
DE60226406D1 (de) Leiterplatte und verfahren zu ihrer herstellung
ATE301662T1 (de) Pyrimidin-4-one derivate, verfahren zu ihrer herstellung and sie enthaltende zusammensetzungen
DE60122295D1 (de) Flavon derivate, verfahren zu deren herstellung und deren verwendung als heilmittel
ATE248171T1 (de) Isoindoloindolon-derivate, verfahren zu ihrer herstellung und die enthaltende pharmazeutische zusammensetzungen
ATE313556T1 (de) Memno-peptide, verfahren zu ihrer herstellung und ihre verwendung
ATE275136T1 (de) Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1256583

Country of ref document: EP

REN Ceased due to non-payment of the annual fee